Distinct epitopes on amiloride.

The American Journal of Physiology
T R KleymanD G Warnock

Abstract

Most Na(+)-selective transport proteins are inhibited by the drug amiloride. Studies using amiloride analogues suggest that specific regions of amiloride might participate in binding to receptors on these transport proteins. To determine whether certain domains of this drug are recognized as distinct epitopes, amiloride was coupled to albumin through either its C-5 NH2-group on the pyrazine ring or through a terminal NH2-group of the guanidino moiety, and antibodies were raised against these amiloride-albumin conjugates. Studies of antibody binding to amiloride analogues identified the 3,5-diaminopyrazinyl, the guanidinocarbonyl, and the C-6 halo moieties as distinct epitopes, although the antibodies required the presence of both the 3,5-diaminopyrazinyl as well as the guanidinocarbonyl moiety for binding.

References

May 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·K Sege, P A Peterson
May 1, 1978·British Journal of Pharmacology·A W Cuthbert, G M Fanelli
Jan 1, 1986·Annual Review of Immunology·G N Gaulton, M I Greene
Apr 1, 1988·Physiological Reviews·H Garty, D J Benos
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W V WilliamsM I Greene
Oct 1, 1988·The Journal of Membrane Biology·T R Kleyman, E J Cragoe
Mar 1, 1972·Immunochemistry·C L Hornick, F Karuch
Apr 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·W R MoyleR E Canfield

❮ Previous
Next ❯

Citations

Aug 22, 1997·The Journal of Biological Chemistry·I I IsmailovT R Kleyman
Apr 26, 1996·The Journal of Biological Chemistry·G C Ellis-DaviesJ H Kaplan

❮ Previous
Next ❯

Related Concepts

Related Feeds